Compare CDMOs specializing in small molecule drug product formulation, tableting, encapsulation, and coating. Filter by dosage form, batch size, and regulatory approvals.
406 companies listed
Small molecule drug product manufacturing turns your API into the tablet, capsule, or injectable a patient actually takes. The hard part isn't making one clinical batch. It's finding a partner who can carry the process from a 20,000-unit Phase I lot to a validated commercial line without a mid-program tech transfer that resets your timeline. Ask three things before you shortlist. Does the CDMO run your dosage form at both clinical and commercial scale under one roof? If your molecule is BCS Class II or IV, do they have real bioavailability-enhancement experience (spray drying, hot melt extrusion, amorphous solid dispersions), or just a brochure? And can they show a batch record and stability package that held up under an FDA pre-approval inspection? The CDMOs below list small molecule drug product as a core capability.
Small molecule drug product manufacturing transforms the API into the final dosage form patients receive. This includes granulation, blending, compression (tablets), encapsulation, film coating, and packaging. Each step requires precise process control to ensure dose uniformity, dissolution performance, and stability.
Bioavailability enhancement is a growing need. Many new chemical entities have poor aqueous solubility (BCS Class II/IV), requiring advanced formulation technologies: spray drying, hot melt extrusion, nanoparticle milling, amorphous solid dispersions, and lipid-based drug delivery systems. CDMOs with these capabilities command premium positioning.
Spain
Galenicum Health is a Spanish specialty pharmaceutical company founded in 2003 in Barcelona, operating as a CDMO with a manufacturing facility near Madrid. The company produces finished dosage forms in multiple formats including liquids, ointments, creams, sachets, powders, nasal sprays, tablets, and capsules, with a production capacity of over 50 million packs per year. Galenicum operates in 58+ countries with 800+ employees and consolidated revenues of 213M EUR (2023).
Argentina
Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company focused on branded and generic formulations, with an API manufacturing arm called Glenmark Life Sciences. The company manufactures APIs and finished dosage forms primarily for its own portfolio, spanning dermatology, respiratory, oncology, and cardiovascular therapeutic areas. Glenmark Life Sciences produces over 120 APIs across multiple manufacturing sites in India.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.